BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10785891)

  • 1. Persistent central diabetes insipidus presenting in a very low birth weight infant successfully managed with intranasal dDAVP.
    Stapleton G; DiGeronimo RJ
    J Perinatol; 2000 Mar; 20(2):132-4. PubMed ID: 10785891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of central diabetes insipidus with oral desmopressin in a premature neonate.
    Atasay B; Berberoğlu M; Günlemez A; Evliyaoğlu O; Adiyaman P; Unal S; Arsan S; Ocal G
    J Pediatr Endocrinol Metab; 2004 Feb; 17(2):227-30. PubMed ID: 15055359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transient diabetes insipidus in a preterm neonate and the challenge of desmopressin dosing.
    Van der Kaay DC; Van Heel WJ; Dudink J; van den Akker EL
    J Pediatr Endocrinol Metab; 2014 Jul; 27(7-8):769-71. PubMed ID: 24670345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Central diabetes insipidus in the very young child. Treatment with oral desmopressin].
    Fjellestad-Paulsen A; Crosnier H; Czernichow P
    Arch Fr Pediatr; 1988 Dec; 45(10):787-90. PubMed ID: 3071285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of DDAVP (1-desamino-8-D-arginine vasopressin) in children with central diabetes insipidus (author's transl)].
    Tomita M; Nakagawa S; Saito N; Sakurada N; Nonoda A
    Horumon To Rinsho; 1979 Jun; 27(6):681-5. PubMed ID: 466837
    [No Abstract]   [Full Text] [Related]  

  • 6. Idiopathic central diabetes insipidus presenting in a very low birth weight infant successfully managed with lyophilized sublingual desmopressin.
    Hanta D; Törer B; Temiz F; Kılıçdağ H; Gökçe M; Erdoğan Ö
    Turk J Pediatr; 2015; 57(1):90-3. PubMed ID: 26613228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of neonatal diabetes insipidus with desmopressin.
    Giacoia GP; Watson S; Karathanos A
    South Med J; 1984 Jan; 77(1):75-7. PubMed ID: 6695224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DDAVP in the treatment of central diabetes insipidus.
    Robinson AG
    N Engl J Med; 1976 Mar; 294(10):507-11. PubMed ID: 1250255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral administration of diluted nasal desmopressin in managing neonatal central diabetes insipidus.
    Mavinkurve M; McGrath N; Johnston N; Moloney S; Murphy NP; Hawkes CP
    J Pediatr Endocrinol Metab; 2017 May; 30(6):623-628. PubMed ID: 28599389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transient gestational diabetes insipidus: report of two cases and review of pathophysiology and treatment.
    El-Hennawy AS; Bassi T; Koradia N; Bocirnea A
    J Matern Fetal Neonatal Med; 2003 Nov; 14(5):349-52. PubMed ID: 14986811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transient diabetes insipidus in a very-low-birthweight preterm infant with intraventricular haemorrhage.
    Molnar Z; Sotiridou E; Dixon H; Ogilvy-Stuart A
    Acta Paediatr; 2012 Sep; 101(9):e389-90. PubMed ID: 22731519
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of diabetes insipidus with Minirin. Switch from nasal to oral administration].
    Czernichow P
    Ann Endocrinol (Paris); 1998 Dec; 59(5):407-9. PubMed ID: 9949892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of central diabetes insipidus using oral DDAVP. Comparison with intranasal treatment].
    Carraro A; Fano M; Porcella E; Bernareggi V; Giusti M
    Minerva Endocrinol; 1991; 16(3):141-5. PubMed ID: 1806811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pregnancy in diabetes insipidus--a case report with review of the literature].
    Cap R; Lüscher KP
    Zentralbl Gynakol; 1990; 112(12):773-8. PubMed ID: 2220171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central Diabetes Insipidus in a Preterm Neonate Unresponsive to Intranasal Desmopressin.
    Hussain A; Baier RJ; Mehrem AA; Soylu H; Fraser D; Elsayed Y
    Neonatal Netw; 2020 Nov; 39(6):339-346. PubMed ID: 33318230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The treatment of patients with diabetes insipidus by a synthetic analogue of vasopressin, DDAVP (author's transl)].
    Tanae A; Shimizu K; Yoshida S
    Nihon Naibunpi Gakkai Zasshi; 1978 May; 54(5):676-91. PubMed ID: 689212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of vasopressin-sensitive diabetes insipidus in children with DDAVP].
    Gerards LJ; van Leeuwen EF; Donckerwolcke RA; Kuijten RH
    Ned Tijdschr Geneeskd; 1975 Aug; 119(33):1269-72. PubMed ID: 1165795
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of diabetes insipidus with 1-deamino-8-d-arginine vasopressin.
    Czakó L; Mezei G; László FA
    Acta Med Acad Sci Hung; 1975; 32(1):75-84. PubMed ID: 1233863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical experience with DDAVP (1-deamino-8-D-arginine vasopressin), a new synthetic analog of vasopressin, in the treatment of childhood diabetes insipidus].
    Lebacq E; David L
    Pediatrie; 1975; 30(3):265-270. PubMed ID: 1178251
    [No Abstract]   [Full Text] [Related]  

  • 20. [Diabetes insipidus--with special reference to DDAVP therapy].
    Shimizu K
    Nihon Rinsho; 1979; 37(4):849-55. PubMed ID: 449070
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.